Cosm Medical Corp.: federal grants and contributions: 15 agreements; $2.9M value; 3 departments; 7 programs.
Assay record ASY-CA-07LYTU41A0 · Cite as: Assay Systems, “Cosm Medical Corp.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/cosm-medical-corp/
To advance the commercialization and scale-up of the artificial intelligence (AI)-powered Gynethotics platform.
Cosm Medical is developing Gynethotics, or custom pessaries, to meet each women’s unique physiology and needs. This project is to work on manufacturing process refinements and mechanical characterization necessary to achieve to milestones for a Health Canada & FDA Submission as an approved medical device.
Completing prototyping, testing, analysis, and manufacturing build out of the Gynethotics necessary for in-human clinical studies.
To support southern Ontario Community Futures Development Corporations in the provision of Canada Emergency Business Account-like loan support to businesses and organizations that have been impacted by the COVID-19 pandemic.
This project aims to enhance our manufacturing processes to address the challenges of producing diverse configurations, ensuring high-quality and consistent products.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.
Development of ultrasound image analysis and parametric (i.e. customizable) Computer Assisted Design (CAD) models of pessaries to treat various types of prolapse and incontinence. These components lead to the development of a software tool chain, essential for the technical and economic viability of customized pessaries, which are referred to as Gynethotics.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
The graduate will be contributing towards a successful launch of Gynethotics by executing day-to-day manufacturing tasks per the production schedule and in accordance with product specifications, quality standards, and business objectives. Some manufacturing tasks include 3D printing, silicone injection, curing, coating application, packaging, and in-process inspection. Graduate will set up and operate equipment, enter process data in computer systems, and interpret/follow written process documentation.
Cosm Medical will employ a youth Product Management Associate.
The project will support development of intellectual property capacity within the firm.
To hire a QA/RA SPECIALIST who will be critical in contributing towards a successful launch of Gynethotics in Canada and the US by owning a key supporting role in the company’s initial certification to MDSAP (ISO 13485:2016) and maintenance of the Gynethotics DHF (Design History File).
The purpose of this CanExport Innovation (CXI) grant agreement is to support organizations and to build on targeted relationships between Canadian companies/researchers and key organizations in other countries to allow them to proceed with formal discussions to initiate collaboration(s) on future international R&D initiatives that could lead to commercialization of Canadian technologies.
The Project will support development of intellectual property capacity within the Firm.
All grants from Federal Economic Development Agency for Southern Ontario
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.